Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Your RPS

RPS policy on type 2 diabetes calls for full integration of pharmacists across NHS systems

A policy document published by the Royal Pharmaceutical Society and endorsed by Diabetes UK says specialist pharmacists across the NHS are vital for patient support and the development of local and national strategy. 

Mahendra Patel, a member of the RPS English Pharmacy Board, led on work to deliver the policy

Source: Nic Bunce / The Pharmaceutical Journal

Mahendra Patel, a member of the Royal Pharmaceutical Society’s English Pharmacy Board, held a workshop with representatives from across healthcare disciplines to help produce the diabetes policy

Pharmacists must be fully integrated into the care of people with type 2 diabetes mellitus (T2DM) in England across all care settings, the Royal Pharmaceutical Society (RPS) has said.

The call for greater pharmacy input within multidisciplinary teams was made in ‘Using pharmacists to help improve care for people with type 2 diabetes’ , a policy document published by the RPS and endorsed by Diabetes UK, on 10 July 2019.

There are 3.8 million people diagnosed with diabetes in England and 90% of them have T2DM. Diabetes is responsible for more than 22,000 premature deaths in England per year. The RPS says most cases could be prevented or delayed by increasing awareness of risk factors and by providing early diagnosis for people at high risk, such as people with diabetes in the family, people with high blood pressure and people who are overweight.

The policy document says that pharmacists across primary care already provide health and wellbeing support, education and point-of-contact testing in places such as schools, supermarkets and places of worship. In the report, the RPS said that this existing infrastructure would lend itself well to efforts to raise awareness of T2DM, and added that the diversity of the pharmacy workforce could help address the “languages and cultural barriers associated with the prevention and management of T2DM”.

The policy document also calls on the NHS to increase the number of advanced practice and consultant diabetes pharmacists across the healthcare system, of which there are currently only two. It says that consultant pharmacists in their specialist fields are vital both for patient support and for the development of local and national strategy.

The report also highlights the need for training to improve pharmacists’ digital literacy capabilities, so that they can support patients to use digital diabetes management tools, such as non-invasive diagnostics and apps, and better understand and interpret clinical data.

Mahendra Patel, a member of the RPS English Pharmacy Board (EPB) who led on work to deliver the policy, said: “As part of our research, we held a workshop with representatives from across the healthcare disciplines — doctors, nurses, nutritionists, dieticians physiotherapists and academics — and there was such an energy and momentum in the room. Pharmacists don’t often shout about what we do, so it was nice to see other medical professionals shouting about what we can do”.

He added that the policy has “come at the right time to align with the new NHS structures”, including primary care networks and integrated care systems.

Claire Anderson, chair of the RPS EPB, said: “Linking pharmacists into the formal structure of care pathways and services has potential to dramatically improve the health of patients. It would create capacity and access in the system, and enable pharmacists to adopt a person-centred approach to diabetes care which helps patients get the most benefit from their medicines.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206786

Readers' comments (1)

  • Picking up the paragraph "He added that the policy has “come at the right time to align with the new NHS structures”, including primary care networks and integrated care systems." Top of my Wish List!!!
    I am T2DM complex needs, in a county that does not have an ulcer care multidisciplinary team. It has taken nearly three years to heal an ulcer on the heal. Nearly continuous antibiotics and a UTI along the way now mobility impaired from sitting with my feet elevated bandaged to the knee. Yes better than an amputation, but at what cost either way, surely these new structures will expedite recovery and a better quality of life for the patient.

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
PJJ Static MPU
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.